Continues. Bayer will buy america consumer over the counter business for 14. 2 billion. Also the two companies are establishing a have a teemgic collaboration in cardiovascular diseases. And this will vowill involve me paying 2 billion to bayer. But again, the big headline here is the 14. 2 billion deal for mercks over the counter consumer business. Why is there so much deal making going on in pharmaceuticals . This has been incredible. Weve seen a swap from glaxo and novartis. This is a way for companies to hone in on what theyre good at. Were hearing a lot of pharmaceutical companies saying they need scale, they need to cut costs and they want to be number one or two in positions where theyre playing. So areas where theyre a little bit smaller, were seeing these asset swaps. And now of course this is all set against the backdrop of pfizer making its 106 billion bid for astrazeneca which is eclipsing Everything Else going on in the industry. But this is a big deal for merck and one it
Alaska
United-states
China
California
Russia
Washington
District-of-columbia
Connecticut
Ukraine
San-francisco
Massachusetts
Panama